KENILWORTH, N.J., Oct. 17 /PRNewswire-FirstCall/ -- Schering-Plough
Corporation (NYSE: SGP) today announced the transition of leadership of its
Animal Health unit from Ruurd Stolp, D.V.M., Ph.D., to Raul E. Kohan, who
was previously the Deputy Head of the Animal Health unit. In his role as
senior vice president and president, Intervet/Schering-Plough Animal
Health, Kohan will continue reporting to Fred Hassan, chairman and chief
executive officer.
In this role, Kohan is responsible for overseeing the company's
worldwide animal health business, which includes a range of
pharmaceuticals, vaccines and services for food-producing and companion
animals. The role is based in Boxmeer, the Netherlands, where the Animal
Health unit is headquartered.
Kohan joined Schering-Plough in 1984 and has since held positions of
increasing responsibility. He recently served as Deputy Head of Animal
Health and senior vice president, Corporate Excellence and Administrative
Services for Schering-Plough Corporation. Previously, Kohan's
responsibilities included overseeing the company's Global Specialty
Operations group, which comprised Animal Health and Consumer Health Care
for Schering-Plough.
Kohan graduated from the General San Martin Military Academy,
Argentina, and holds an M.B.A. degree in economics from the University of
Buenos Aires.
Stolp will transition responsibilities to Kohan over the next several
months. During his 21 years with Intervet, Stolp held various roles of
increasing responsibility within the Animal Health unit. Previously, Stolp
was president of Intervet International, a position he held since 2002.
"Ruurd and Raul played critical leadership roles in our successful
combination of Organon BioSciences with Schering-Plough over the past
year," said Hassan. "I thank Ruurd for his leadership, guidance and
important contributions bringing our two companies together. Raul and I
look forward to working with him in an advisory capacity."
Schering-Plough is an innovation-driven, science-centered global health
care company. Through its own biopharmaceutical research and collaborations
with partners, Schering-Plough creates therapies that help save and improve
lives around the world. The company applies its research-and-development
platform to human prescription and consumer products as well as to animal
health products. Schering-Plough's vision is to "Earn Trust, Every Day"
with the doctors, patients, customers and other stakeholders served by its
colleagues around the world. The company is based in Kenilworth, N.J., and
its Web site is http://www.schering-plough.com.
Media Contact
Steve Galpin, Jr.
+1 908 298 7415
Sabine Schueller
+31 485 58 7085
Investor Contacts
Janet Barth
Joseph Romanelli
+1 908 298 7436
SOURCE Schering-Plough Corporation
 back to top
Related links:
http://www.schering-plough.com
CONTACT:
Steve Galpin, Jr., +1 908 298 7415, Sabine
Schueller, +31 485 58 7085; or Investor Contacts, Janet Barth, or
Joseph Romanelli, +1 908 298 7436
|
